Prof. Stefan Przyborski to participate at the XCellR8 Human Primary Cell Culture course, 7 November 2013
22 August 2013
Reinnervate’s CSO, Professor Stefan Przyborski, will be participating at the XCellR8 Human Primary Cell Culture course, which will be held on 7-8 November 2013 at their new premises in the Sci-Tech Daresbury Innovation Centre, UK.
As part of the two-day course, on 7th November Prof. Przyborski will be giving a presentation explaining Alvetex® 3D cell culture technology. He will also be a panelist in a debate/Q&A session on various 3D cell culture methods, and how to choose the method to suit your application.
XCellR8 Ltd maximizes the productivity of cell culture based research for its cosmetic formulation and pharmaceutical customers by providing independently certified in vitro contract testing and specialist training & best-practice guidance. Contact Dr Carol Barker Managing Director on 07899 845222 or by email email@example.com
About Sci-Tech Daresbury
Sci-Tech Daresbury is a world-class location for high-tech business and leading-edge science-based in Cheshire. It provides a unique environment for innovation and business growth, with knowledge sharing, collaboration, and networking.
Home to the ground-breaking STFC Daresbury Laboratory and the Cockcroft Institute as well as over 100 high-tech companies, the site was originally established in 2006. In December 2010 a new private-public joint-venture partnership was created to spearhead the longer-term development of the campus. Partners in the private-public joint-venture partnership are developers, Langtree, the Science and Technology Facilities Council (STFC), and Halton Borough Council.
Originally named Daresbury Science and Innovation Campus, the campus’ name was changed in July 2012 to reflect its new Enterprise Zone status, which was granted in April 2012. Enterprise Zone status allows business rates to be reinvested in the campus, potentially creating up to 15,000 skilled jobs and providing funding for the new specialist office, laboratory, and technical space. Enterprise Zone status will also allow the campus to leverage more than £150million in private sector investment.
Note:Reinnervate Ltd (County Durham, England) was acquired by REPROCELL Inc (Yokohama, Japan) in August 2014. Biopta Ltd (Glasgow, Scotland) was acquired by REPROCELL in November 2015. REPROCELL Europe Ltd was established by merging Reinnervate and Biopta in June 2016.